Standard lab ranges flag disease. They do not identify the earlier window in which your body is already showing stress, dysfunction, or declining performance. Optimal ranges answer a different question: is this marker where it should be for long-term resilience?

The Verdict

Normal is a floor. Optimal is a target. Most people stop feeling their best long before they qualify for a diagnosis — because standard ranges are built to detect disease, not to preserve function.

What a reference range actually is

A lab reference range is not a health recommendation. It is a statistical summary. A lab measures a reference group, plots the distribution, and prints the central 95% — everything between the 2.5th and the 97.5th percentile.

Two consequences follow directly from that method. By construction, one in twenty healthy people falls outside any given range. And if the reference group carries a high background rate of disease, that disease is baked into "normal." American ApoB reference ranges describe a population in which cardiovascular disease is the leading cause of death.

Ranges are also assay-specific and lab-specific. The same blood, split between two labs, can return the same value against two different printed ranges. That is why trending a marker at one lab beats comparing absolute numbers across providers.

The gap, biomarker by biomarker

BiomarkerLab 'normal'Optimal targetWhy the standard range sits where it does
Fasting insulin Under 25 μIU/mL 2–5 μIU/mL The range was built to catch severe hyperinsulinemia, not early resistance.
Fasting glucose Under 100 mg/dL 75–90 mg/dL The 100 cutoff defines prediabetes. Risk rises measurably below it.
HbA1c Under 5.7% 4.9–5.3% 5.7% is a disease threshold, not a health target.
ApoB Up to ~130 mg/dL Under 80 mg/dL The reference population has a high background rate of heart disease.
hsCRP Under 3.0 mg/L Under 0.5 mg/L Guidelines call 1–3 mg/L "average risk" — average is not low.
Homocysteine Under 15 μmol/L Under 8 μmol/L The 9–15 band sits inside "normal" and carries most of the risk association.
Ferritin (men) Above 12–30 ng/mL 50–150 ng/mL The lower bound marks absent marrow iron, not adequate function.
Ferritin (women, premenopausal) Above 12–15 ng/mL 50–100 ng/mL Symptoms of iron deficiency commonly appear below 30–50 ng/mL.
Vitamin D (25-OH) Above 20–30 ng/mL 40–60 ng/mL 20 ng/mL was set to prevent bone disease, not to optimize anything else.
TSH 0.4–4.5 mIU/L 0.5–2.5 mIU/L The upper bound includes people with undiagnosed thyroid disease. Actively debated.
Total testosterone (men) ~300–1,000 ng/dL Upper half for age, with SHBG Age-stratified ranges include unwell older men, which drags the floor down.
Omega-3 index Not usually reported Above 8% No standard range exists — it is a research-derived risk measure.

Where the two ranges disagree most

Three examples show how differently the two frameworks read the same result.

  • Ferritin. The lower reference bound of roughly 12–15 ng/mL comes from the level at which bone marrow iron stores are effectively absent. That is a threshold for a diagnosis of iron deficiency anemia. Fatigue, hair shedding, and reduced exercise tolerance commonly appear below 30–50 ng/mL, well inside the "normal" band.
  • TSH. The upper reference bound of 4.5–5.0 mIU/L was set from populations that included people with undiagnosed autoimmune thyroid disease. When those individuals are excluded, the upper limit in disease-free populations falls closer to 2.5–3.0. Whether that lower ceiling should be used clinically remains an open dispute, and this page will not pretend otherwise.
  • Testosterone in men. Age-stratified ranges describe what older men actually have, including those with obesity, sleep apnea, and chronic illness. Comparing a 60-year-old against that group answers "am I typical," not "am I well."

Why the gap matters clinically

Most chronic disease develops across decades of slow drift. Insulin resistance precedes type 2 diabetes by ten to fifteen years. Atherosclerosis begins in the twenties. Bone loss starts before any fracture. In each case the reference range stays quiet through the entire reversible phase and only speaks up once the diagnosis has arrived.

That is the practical cost of using disease thresholds as health targets. The window where intervention is cheapest, safest, and most effective is precisely the window in which every number reads normal.

How to test so the numbers mean something

  • Standardize the conditions. Same lab, morning draw, fasted, similar hydration, and away from intense training. Most "changes" between two tests are collection differences.
  • Avoid testing during or just after acute illness. Infection distorts inflammatory markers, lipids, iron studies, and thyroid tests simultaneously.
  • Stop high-dose biotin for 72 hours. It interferes with many hormone and thyroid immunoassays and produces plausible-looking wrong answers.
  • Repeat before you act. One abnormal value on a wide panel is more likely to be variation than disease.
  • Allow enough time after a change. Lipids need 6–8 weeks, HbA1c around 3 months, the omega-3 index 3–4 months, and ferritin 8–12 weeks.
  • Keep your own record. A five-year trend line is more informative than any single result compared against a printed range.

Reading patterns instead of values

Individual markers are noisy. Groups of related markers are not, because a real physiological problem shows up in several places at once.

  • Metabolic pattern: fasting insulin above 8, triglyceride-to-HDL ratio above 3, ALT rising, and SHBG falling. Four "normal" values describing one problem.
  • Cardiovascular pattern: ApoB above 90, Lp(a) elevated, hsCRP above 2. Particles, inheritance, and inflammation stacked.
  • Nutritional pattern: homocysteine above 10, low-normal B12, ferritin under 40, omega-3 index under 5%. Several correctable inputs at once.
  • Thyroid pattern: TSH above 3, free T4 low-normal, plus fatigue and cold intolerance. The symptoms carry as much weight as the numbers here.

What to do with a result

  • Do not react to a single number. One marker off is a data point, not a diagnosis.
  • Look for agreement. Three related markers pointing the same way is a pattern, and a pattern is what justifies a plan.
  • Test what standard panels skip. Fasting insulin, ApoB, Lp(a), hsCRP, homocysteine, omega-3 index, full thyroid, and free testosterone with SHBG.
  • Change one thing at a time. Starting five interventions at once makes the next result uninterpretable.
  • Repeat over time. One result is a snapshot; a series is a trajectory, and the trajectory is what you are actually managing.

When a result warrants seeing a physician

  • Any value far outside the reference range, rather than merely outside an optimal target.
  • An abnormal result that repeats on a second draw, particularly for kidney function, liver enzymes, or blood counts.
  • Any lab finding accompanied by symptoms — unexplained weight loss, fever, night sweats, chest pain, or new breathlessness.
  • Ferritin above 300 ng/mL in men or 200 ng/mL in women, which warrants investigation for iron overload or inflammation.
  • Before starting any prescription intervention based on an "optimal range" argument, including thyroid or hormone therapy.

Frequently Asked Questions

What is the difference between normal and optimal lab ranges?

A "normal" range is a statistical description: the central 95% of results from a reference population. It answers whether you resemble the people the lab measured. An optimal range is drawn from outcome research and answers a different question — at what value do people do best over decades. One is a description of a population, the other is a target.

How is a reference range actually built?

A lab collects samples from a reference group, then takes the central 95% of the distribution — the 2.5th to 97.5th percentile. Two consequences follow. First, 1 in 20 perfectly healthy people fall outside any given range by construction. Second, if the reference group is unhealthy, "normal" inherits that. Reference ranges are also assay-specific, which is why they differ between labs.

Why do standard doctors use normal ranges instead of optimal?

Standard care is built to detect and treat disease, and reference ranges are well suited to that. A fasting glucose of 99 mg/dL is not a diagnosis and does not trigger a treatment pathway, so it passes without comment. That is not negligence — it is a different question being asked. Prevention-oriented care asks whether the trajectory is right, which needs a narrower target.

If I run a big panel, will something always look abnormal?

Probably. Each individual test has about a 1 in 20 chance of falling outside its reference range in a healthy person. Across a 20-marker panel, the chance that at least one comes back flagged is roughly 64%. That is why a single borderline value on a large panel is weak evidence on its own, and why repeating the test before acting is standard practice.

Is it worth chasing perfect numbers?

No. The goal is to interpret patterns, not to optimize each line item. A fasting insulin of 18 μIU/mL matters because of what it implies about the whole metabolic system, not because 18 is an unlucky number. Chasing individual values invites over-supplementation, unnecessary medication, and a lot of anxiety over normal biological variation.

Are optimal ranges evidence-based or invented?

It varies by marker, and the answer differs case by case. ApoB and hsCRP targets come from large trials and guideline bodies. The omega-3 index target comes from published cohort research. The TSH upper limit of 2.5 mIU/L is a genuine and unresolved dispute among endocrinologists. Anyone presenting every optimal range as settled science is overstating the evidence.

Related